CORC

浏览/检索结果: 共39条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Preparation and performance of UHMWP modified asphalt and its high modulus mixture 期刊论文
CONSTRUCTION AND BUILDING MATERIALS, 2021, 卷号: 294
作者:  Wang, Chaohui;  Zhou, Xiaolei;  Yuan, Huazhi;  Chen, Haoyu;  Zhou, Liwei
收藏  |  浏览/下载:7/0  |  提交时间:2021/10/14
Third-generation EGFR inhibitor HS-10296 in combination with famitinib, a multi-targeted tyrosine kinase inhibitor, exerts synergistic antitumor effects through enhanced inhibition of downstream signaling in EGFR-mutant non-small cell lung cancer cells 期刊论文
THORACIC CANCER, 2021, 页码: 9
作者:  Zhang, Mi;  Quan, Haitian;  Fu, Li;  Li, Yun;  Fu, Haoyu
收藏  |  浏览/下载:18/0  |  提交时间:2021/05/24
TSL-1502, a glucuronide prodrug of a poly (ADP-ribose) polymerase (PARP) inhibitor, exhibits potent anti-tumor activity in preclinical models 期刊论文
AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 卷号: 11, 期号: 4, 页码: 1632-1645
作者:  Wang, Lei;  Zhu, Xi;  Li, Lili;  Li, Lin;  Fu, Li
收藏  |  浏览/下载:74/0  |  提交时间:2021/06/11
YES1amplification confers trastuzumab-emtansine (T-DM1) resistance in HER2-positive cancer 期刊论文
BRITISH JOURNAL OF CANCER, 2020, 页码: 12
作者:  Wang, Lei;  Wang, Quanren;  Xu, Piaopiao;  Fu, Li;  Li, Yun
收藏  |  浏览/下载:15/0  |  提交时间:2020/12/24
SHR-A1403, a novel c-mesenchymal-epithelial transition factor (c-Met) antibody-drug conjugate, overcomes AZD9291 resistance in non-small cell lung cancer cells overexpressing c-Met 期刊论文
CANCER SCIENCE, 2019, 页码: 11
作者:  Tong, Mengya;  Gao, Mingzhao;  Xu, Yongping;  Fu, Li;  Li, Yun
收藏  |  浏览/下载:21/0  |  提交时间:2020/07/01
Pharmacological characterization of TQ05310, a potent inhibitor of isocitrate dehydrogenase 2 R140Q and R172K mutants 期刊论文
CANCER SCIENCE, 2019, 页码: 9
作者:  Gao, Mingzhao;  Zhu, Hongmei;  Fu, Li;  Li, Yun;  Bao, Xubin
收藏  |  浏览/下载:17/0  |  提交时间:2020/07/01
AG-221  IDH2  leukemia  R140Q  R172K  
Preclinical characterization of SHR6390, a novel CDK 4/6 inhibitor, invitro and in human tumor xenograft models 期刊论文
CANCER SCIENCE, 2019, 卷号: 110, 期号: 4, 页码: 1420-1430
作者:  Long, Fei;  He, Ye;  Fu, Haoyu;  Li, Yun;  Bao, Xubin
收藏  |  浏览/下载:20/0  |  提交时间:2020/07/01
Pharmacologic characterization of fluzoparib, a novel poly(ADP-ribose) polymerase inhibitor undergoing clinical trials 期刊论文
CANCER SCIENCE, 2019, 卷号: 110, 期号: 3, 页码: 1064-1075
作者:  Wang, Lei;  Yang, Changyong;  Xie, Chengying;  Jiang, Jiahua;  Gao, Mingzhao
收藏  |  浏览/下载:22/0  |  提交时间:2020/07/01
Pharmacologic characterization of fluzoparib, a novel poly polymerase inhibitor undergoing clinical trials 期刊论文
Cancer Science, 2019, 卷号: Vol.110 No.3, 页码: 1064-1075
作者:  Lei Wang;  Changyong Yang;  Chengying Xie;  Jiahua Jiang;  Mingzhao Gao
收藏  |  浏览/下载:12/0  |  提交时间:2019/12/13
Preclinical characterization of SHR6390, a novel CDK 4/6 inhibitor, in vitro and in human tumor xenograft models. 期刊论文
Cancer science, 2019
作者:  Fei Long;  Ye He;  Haoyu Fu;  Yun Li;  Xubin Bao
收藏  |  浏览/下载:22/0  |  提交时间:2019/12/17


©版权所有 ©2017 CSpace - Powered by CSpace